Metabolic syndrome and obstructive sleep apnea syndrome among patients with epilepsy on monotherapy.

CONCLUSION: Higher frequency of MetS and OSAS risk should be kept in mind on clinical follow-up of patients with epilepsy receiving monotherapy. PMID: 32769040 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32769040?dopt=Abstract

Source: Epilepsy and Behaviour - August 4, 2020 Category: Neurology Authors: Söylemez E, Öztürk O, Baslo SA, Balçık ZE, Ataklı D Tags: Epilepsy Behav Source Type: research